Straumann® Dental Implant System

More than an implant.A sense of trust.

SDIS_Broschure.indd 1 17.12.13 15:05

2

When patients need a tooth replacement, you want to provide them with the best possible solution and exceed their expec-tations. The Straumann® Dental Implant System is designed to support you in this process by improving treatment outcomes built on a history of pioneering implant dentistry and reliable scientific evidence.

More than an implant. A sense of trust.

Trust based on 60 years of qualityand innovations

1954Founding of the research instituteInstitut Dr. Ing. R. Straumann AG

1997SLA® – Pioneering surface technology cuts healing time in half1

1974First dental implants including the world’s first one-stage implant are developed at Straumann

SDIS_Broschure.indd 2 17.12.13 15:05

3

NumbeR of StuDy pubLIcAtIoNS AND peeR-RevIeweD pubLIcAtIoNS oN StRAumANN pRoDuctS

2009Roxolid® – The new “DNA” of implant materials. Exclusively designed for the use in dental implantology

2005SLActive® surface technology reduces reported implant loss rate to 0.6 %2

2013Introducing the full Roxolid® portfolio – setting new standards by reducing invasiveness

0 50 100 150 200

2012 31 16 130

2011 39 24 130

2010 28 54 130

2009 37 33 120

2008 37 20 100

Preclinical Clinical Peer-reviewed

SDIS_Broschure.indd 3 17.12.13 15:05

4

More than flexible.A new kind of esthetics.

For a natural look and feel. The Straumann® Bone Level Implant Line provides great flexibility to deliver an es-thetically pleasing solution to patients.

Simplified handling with the crossfit® connection

ѹ Makes handling easier and provides confidence about component positioning

ѹ Ensures precision against rotation ѹ Offers restorative flexibility and

long-term mechanical stability

pleasing esthetic results with consistent emergence profiles™

ѹ Optimizes and simplifies soft tissue management

ѹ Eases the fabrication of tempo-rary and final restorations

optimized crestal bone preser-vation with bone control Design™

ѹ Respects the biological distance/width

ѹ Optimal position of smooth and rough surface interface

ѹ Microgap control ѹ Biomechanical implant design ѹ Implant surface osteoconductivity

well-proven new materials

ѹ Titanium Grade 4 ѹ Roxolid®: A titanium-zirconium

alloy stronger than titanium6,7 and specifically designed for the use in dental implantology

SDIS_Broschure.indd 4 17.12.13 15:05

5

More than efficient.A simple procedure.

The Straumann® Soft Tissue Level Implants are designed to simplify treatment. The one-stage surgical procedure will al-low you to save time and increase efficiency in your practice. Cover a wide range of indications with 3 different implant lines – Standard, Standard Plus and Tapered Effect.

Innovative surfaces

ѹ SLA®, the reliable and scientifically well-documented surface, with predictable long-term clinical data3,4

ѹ SLActive®, the next generation in implant surface technology reduc-es the critical healing period down to 3 – 4 weeks5 and minimizes the potential for early implant failure

flexible and reliable with the synocta® connection

ѹ The internal octagon: Secure and flexible (re)positioning of individ-ual abutments in the implant

ѹ Morse taper connection: Uniform load distribution and reliable, stable implant-to-abutment joints prevent rotation

take advantage of the easy accessibility to the implant by work-ing at soft tissue level

ѹ Lean prosthetic portfolio suppor- ted by the implant design

ѹ Simple impression taking and abutment placement thanks to the connection at soft tissue level

SDIS_Broschure.indd 5 17.12.13 15:05

6

More than a surface.A new level of confidence.

HIGHeR pReDIctAbILIty5,21

Most implant failures occur in the critical early period between weeks 2 and 422. Although similar healing pat-terns were observed for both SLA® and SLActive® Implants, bone-to-implant contact (BIC) was greater after 2 weeks and significantly greater after 4 weeks for SLActive® (p < 0.05).23

pRomotIoN of boNe ReGeNeRAtIoN IN DeHISceNce-type DefectS24,25

Critical situations such as dehiscence defects are always a chal-lenge and put success at risk. With SLActive®, new bone vol-ume and BIC are significantly higher. Preclinical studies in dogs showed that SLActive® Implants promote the production of more mature bone than SLA® Implants would. This outcome suggests that SLActive® may have a high potential for support-ing osseointegration in dehicence-type defects.

1 2 3 4 5 6

Healing periods in weeks

New

bon

e on

the

impl

ant s

urfa

ce

SLA®SLActive®

0

70 %

60 %

50 %

40 %

30 %

20 %

10 %

0 %

SLActive® – simply better. Our hydrophilic SLActive® surface is designed to deliver:

ѹ Higher security and faster osseointegration for every indication14-20

ѹ Reduced healing times from 6 – 8 weeks down to 3 – 4 weeks14-19

ѹ Increased treatment predictability in critical protocols20

SLA®5 % BIC after 12 weeks

SLActive®80 % BIC after 12 weeks

SDIS_Broschure.indd 6 17.12.13 15:05

7

More than solid.Less invasive.

Roxolid® is a groundbreaking material specifically designed for the use in dental implantology. The titanium-zirconium alloy is stronger than pure ti-tanium6,7 and has excellent osseointegration prop-erties8-10. This combination of properties is unique in the market – there is no other metallic alloy which unifies high mechanical strength and osteoconductivity.

pReSeRve boNe AND ReDuce INvASIve GRAftING pRoceDuReS11,12

Roxolid® might allow you to choose smaller im-plants. These implants have the potential to pre-serve peri-implant structures and avoid invasive bone grafting procedures.

INcReASe pAtIeNt AcceptANce wItH LeSS INvASIve pRoceDuReS13

Treating patients without invasive grafting proce-dures offers your patients a less traumatic, faster treatment at lower cost. These advantages have the potential to make dental implant treatments appealing to more patients.

10 %

0 %

20 %

30 %

40 %

50 %

60 %

YES NO Augmentation had to be performed

despite 3.3 mm implant

moRe tReAtmeNt optIoNS wItH SmALLeR ImpLANtS

Thanks to their outstanding biological and me-chanical properties, Roxolid® Implants offer more treatment options than conventional small titani-um implants.

Case treated with Straumann® Standard Plus 4 mm Implants

couLD A boNe AuGmeNtAtIoN pRoceDuRe be AvoIDeD by uSING RoxoLID® 3.3 mm ImpLANtS?11

Tens

ile s

tren

gth

(MPa

)

ASTM TiGr43 Straumann® cold-worked

TiGr44

Straumann® Roxolid®4

1000

800

600

400

+ ~75 %

+ ~20 %

54 %

25 % 21 %

SDIS_Broschure.indd 7 17.12.13 15:05

8

More than many possibilities. Just Freedom.

moRe fActS. moRe expeRIeNce.tItANIum SLA®

moRe optIoNS. INcReASeD peRfoRmANce. RoxoLID® SLA®

more treatment options with smaller implants ѹ More treatment options thanks to smaller

implants with higher material strength6,7

ѹ Confidence thanks to the excellent mechanical and biological performance of Roxolid®

preserve bone and reduce invasive grafting procedures11,12

ѹ Wide usage of small implants protects vital structures and vascularization

ѹ Reduced implant size can eliminate the need of GBR procedures for specific cases

Increase patient acceptance with less invasive procedures13

ѹ Reduced invasiveness might increase accep-tance of implant treatment as connected with less discomfort, cost and time

ѹ Increase your business performance

Long-term reliability supported by scientific evidence ѹ Various studies show a high success rate with

SLA® after 10-year follow up3,4

ѹ Over 100 peer-reviewed papers published

unique access to two implant approaches: the original Soft tissue Level Implant Line and the innovative bone Level Implant Line ѹ Esthetic cases can be treated with Bone

Level Implants ѹ Efficient straight forward procedure with

the original Soft Tissue Level Implants ѹ One surgical kit for all implant lines

Support by Straumann quality and services ѹ Highest precision abutment-implant fit

with original parts ѹ Extensive education program offering

new possibilities and generating professional network

ѹ Comprehensive service program including life-time warranty on implants

SDIS_Broschure.indd 8 17.12.13 15:05

9

moRe SecuRIty. moRe peAce of mIND. RoxoLID® SLActive®

Higher security in all indications14-20

ѹ Straumann’s best material-surface combination

ѹ Improved treatment predictability ѹ Minimize the risk of early implant failures

predictable treatment success even in challenging cases9,20,25

ѹ Promotion of bone regeneration in dehiscence-type defects24,25

ѹ Preclinical study indicating increased bone quality in an osteoporotic model9

ѹ High success rates with immediate loading protocols20

practice differentiator offering new treatment possibilities ѹ More patient friendly treatment options ѹ Vertical space is no longer a limitation with

the Standard Plus Short Implant ѹ Predictable immediate loading protocols

reducing treatment time20

SDIS_Broschure.indd 9 17.12.13 15:05

10

More than a restoration.A perfect fit for all needs.

For both Soft Tissue Level and Bone Level Implants, Straumann offers a broad range of standard and CAD-CAM abutments in leading materi-als and a full application range – de-signed to create the optimal restor-ative result for virtually any case.

For ease of use, you need only one restorative kit for both Soft Tissue Level and Bone Level Implants. This single kit is easy to master, simple to handle and allows for convenient component management.

ScRew-RetAINeD ReStoRAtIoNS*/**

cemeNt-RetAINeD*/**

* certain solutions can also be used for screw-retained or cement-retained restorations** only a selection of solution examples is displayed

Standard solutions customized solutions

Gold Abutment Multibase synOcta® 1.5 Variobase™ Screw-retained bridges

Ceramic customized abutment

Standard solutions customized solutions Hybrid restorations**

Cementable Solid Customized abutments LOCATOR® Bar SFI-Anchor® Screw-retained bars

SDIS_Broschure.indd 10 17.12.13 15:05

11

More than just a transfer piece.Easy handling.

The Straumann® Roxolid® Implants are delivered with the new Loxim™ Transfer Piece, which is connected to the implant with a snap-in mounting.

Snap-in mounting …

Blue color …

Compact dimensions …

Height markings …

Pre-determined breaking point …

… for easy handling without counter-maneuvering

… for high visibility

… for easy access

… for correct implant placement

… for protecting the inner implant configuration

feAtuReS beNefItS

SDIS_Broschure.indd 11 17.12.13 15:05

12

Some patients have a thin gingiva biotype, and therefore re-quire a different treatment approach, while other patients ex-press their explicit wish for a metal-free alternative. With the new Straumann® PURE Ceramic Implant we offer an esthetic solution that allows you to treat patients with these specific needs and demands.

More than a tooth-colored implant.Unique natural esthetics.

tHIS SoLutIoN IS bASeD oN DecADeS of StRAumANN’S expeRIeNce AND kNow-How IN ImpLANt DeNtIStRy

ѹ Revolutionary healing patterns comparable to titanium implants thanks to the ZLATM surface26,27

ѹ Reliable implant strength as every implant is proof-tested before release ѹ High end esthetic solution thanks to the ivory-colored material ѹ Expand your patient pool with an innovative metal-free solution

100%

PRO

OF-TESTED • 100% PROOF-TESTED •

SDIS_Broschure.indd 12 17.12.13 15:05

13

The Straumann® Surgical Kit and Prosthetic Kit can be used for all implant lines of the Straumann® Dental Implant System.

More than convenience.A simple workflow.

SAm

e fo

R ALL

tReAtmeNtS

• SuRGIcAL kIt

• pRoStHetIc kIt

• pRoceDuRe

SDIS_Broschure.indd 13 17.12.13 15:05

14

SDIS_Broschure.indd 14 17.12.13 15:05

15

RefeReNceS

1 Scacchi M. et al., The development of the ITI DENTAL IMPLANT SYSTEM. Part 2: 1998-2000: Steps into the next millennium. Clin Oral Implants Res 2000; 11: 22-32 2 Based upon global Straumann® SLActive® complaint statistics 2005-2006 3 Fischer K., Stenberg T. al ‘Prospective 10-year Cohort Study Based on a Randomized Controlled Trial (RCT) on Implant-Supported Full-Arch Maxillary Prostheses. Part 1: Sandblasted and Acid-Etched Implants and Mucosal Tissue.’ Clin Implant Dent Relat Research. 2012 Dec;14(6):808-15 4 Fischer K, Stenberg T. ‘Prospective 10-year cohort study based on a randomized, con-trolled clinical trial (RCT) on implant-supported full-arch maxillary prostheses. Part II: Prosthetic outcomes and maintenance.’ Clin Implant Dent Relat Research.. 2013 Aug;15(4):498-508 5 Oates TW. et al. ‘Enhanced implant stability with a chemically modified SLA® surface: a randomized pilot study.’ Int. J. Oral Maxillofac. Implants. 2007;22(5):755–760. 6 Norm ASTM F67 (states min. tensile strength of annealed titanium). 7 Data on file for Straumann cold-worked titanium and Roxolid® Implants. 8 Gottlow J et al. ‘Evaluation of a new titanium-zirconium dental implant: a biomechanical and histolog-ical comparative study in the mini pig.’ Journal of Clinical Implant Dentistry and Related Research 2012; 14: 538-545 9 Wen B et al. ‘The osseointegration behavior of titanium-zirconium implants in ovariectomized rabbits.’ Clin Oral Implants Res. 2013 Feb 21. 10 Barter S et al. ‘A pilot study to evaluate the success and survival rate of titanium-zirconium implants in partially edentulous patients: results after 24 months of follow-up.’ Clin Oral Implants Res. 2012 Jul;23(7):873-81 11 Freiberger P, Al-Nawas B. ‘Non-interventional Study on Success and Survival of TiZr Implants.’ EAO 2012 Copenhagen; 305 Post-ers – Implant Therapy Outcomes, Surgical Aspects 12 Benic GI et al. ‘Titanium-zirconium narrow-diameter versus titanium regular-diameter implants for anterior and premolar single crowns: 1-year results of a randomized controlled clinical study.’ Journal of Clinical Periodontology 2013; [Epub ahead of print] 13 If a GBR procedure can be avoided 14 Buser D. et al. ‚Enhanced bone apposition to a chemically modified SLA titanium surface.’ J. Dent. Res. 2004 Jul;83(7):529–33. 15 Schwarz F. et al. ‘Histological and immunohistochemical analysis of initial and early osseous integration at chemically modi-fied and conventional SLA® titanium implants: Preliminary results of a pilot study in dogs.’ Clin. Oral Impl. Res. 2007;11(4):481–488. 16 Schwarz F, et al. ‘Histological and immunohistochemical analysis of initial and early subepithelial connective tissue attachment at chemically modified and conventional SLA® titanium implants. A pilot study in dogs.’ Clin. Oral Impl. Res. 2007;11(3):245–455. 17 Schwarz F, et al. ‘Effects of surface hydrophilicity and microto-pography on early stages of soft and hard tissue integration at non-submerged titanium implants: An immunohistochemical study in dogs.’ J. Periodontol. 2007;78(11):2171–2184. 18 Schwarz F,et al. ‘Bone regeneration in dehiscence-type defects at chemically modified (SLActive) and conventional SLA titanium: A pilot study in dogs.’ J. Clin. Periodontol. 2007;34(1):78–86. 19 Zöllner et al. ’Immediate and early non-occlusal loading of Straumann implants with a chemically modified surface (SLActive®) in the posterior mandible and maxilla: interim results from a prospective multicentre randomized-controlled study.’ Clinical Oral Implants Research, 19(5), 442-450,2008. 20 Nicolau P. et al. ‘Immediate and early loading of chronically modified implants in posterior jaws: 3-year results from a prospective randomized study‘ Clin Implant Dent Relat Res. 2013 Aug;15(4):600-612 21 Bornstein mm et al. ‘Early loading at 21 days of non-submerged titanium implants with a chemically modified sandblasted and acid-etched surface: 3-year results of a prospective study in the posterior mandible’. J. Periodontol. 2010 Jun;81 (6):809–18. 22 Raghavendra S, et al. Int. J. Oral Maxillofac. Implants. 2005 May–Jun;20(3):425–31. 23 Lang, NP., et al. ‘Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans.’ Clin Oral Implants.Res 22.4 (2011): 349–56 24 Schwarz, F., et al., ‘Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA titanium implants: a pilot study in dogs’ J Clin.Periodontol. 34.1 (2007): 78–86 25 Schwarz, F., et al., ‘Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA titanium implants: an immunohistochemical study in dogs.’ J Clin.Periodontol. 35.1 (2008): 64–75. 26 Gahlert M et al. ‚ In vivo performance of zirconia and titanium implants: a histomorphometric study in mini pig maxillae.’ Clin Oral Implants Res. 2012 Mar;23(3):281-6 27 Bormann KH et al. ‚ Biomechanical evaluation of a microstructured zirconia implant by a removal torque comparison with a standard Ti-SLA implant.’ Clin Oral Implants Res. 2012 Oct; 23(10):1210-6

SDIS_Broschure.indd 15 17.12.13 15:05

International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01 www.straumann.com

© Institut Straumann AG, 2014. All rights reserved.Straumann® and/or other trademarks and logos from Straumann® mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates. All rights reserved. St

raum

ann

prod

ucts

are

CE

mar

ked

01/1

4 45

2.00

2/A/

000

SDIS_Broschure.indd 16 17.12.13 15:05